Asston Pharmaceuticals
75.00
-3.00(-3.85%)
Market Cap₹63.85 Cr
PE Ratio-
Company Performance:
1D-3.85%
1M-8.48%
6M-27.99%
1Y-39.98%
5Y-39.98%
View Company Insightsright
More news about Asston Pharmaceuticals
13Oct 25
Key Personnel Changes at Asston Pharmaceuticals: CFO and Company Secretary Resign
Asston Pharmaceuticals Limited announced the resignation of two key personnel. Deven Manohar Patil, the Chief Financial Officer, and Vandana Mishra, the Company Secretary and Compliance Officer, have both stepped down from their positions effective October 13, 2025. Both cited the pursuit of new career opportunities outside the company as their reason for leaving. The company's Whole Time Director, Saili Jayaram More, filed regulatory disclosures in compliance with SEBI regulations to inform stakeholders of these changes.
 no imag found
31Jul 25
Asston Pharmaceuticals Secures USD 279,000 International Order from West African Pharma Company
Asston Pharmaceuticals Limited has received a purchase order worth USD 279,000 from a West African pharmaceutical company for various pharmaceutical products. The order is to be executed within 60 days and is not a related party transaction. This international order demonstrates Asston's growing global presence and operational efficiency in the pharmaceutical market.
 no imag found
Asston Pharmaceuticals
75.00
-3.00
(-3.85%)
1 Year Returns:-39.98%
Industry Peers
Waaree Energies
2,726.60
(-0.47%)
Apar Industries
8,989.00
(-4.94%)
Premier Energies
781.85
(-0.95%)
Vikram Solar
181.31
(-1.88%)
Avalon Technologies
879.20
(-3.69%)
Saatvik Green Energy
352.20
(-2.55%)
Shilchar Technologies
3,727.40
(-2.69%)
Oriana Power
1,762.60
(-1.04%)